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Background: Reducing the production cost of, and increasing revenues from, industrial biofuels will greatly
facilitate their proliferation and co-integration with fossil fuels. The cost of feedstock is the largest cost in most
fermentation bioprocesses and therefore represents an important target for cost reduction. Meanwhile, the
biorefinery concept advocates revenue growth through complete utilization of by-products generated during
biofuel production. Taken together, the production of biofuels from low-cost crude glycerol, available in oversupply
as a by-product of bioethanol production, in the form of thin stillage, and biodiesel production, embodies a
remarkable opportunity to advance affordable biofuel development. However, few bacterial species possess the
natural capacity to convert glycerol as a sole source of carbon and energy into value-added bioproducts. Of
particular interest is the anaerobe Clostridium pasteurianum, the only microorganism known to convert glycerol
alone directly into butanol, which currently holds immense promise as a high-energy biofuel and bulk chemical.
Unfortunately, genetic and metabolic engineering of C. pasteurianum has been fundamentally impeded due to lack
of an efficient method for deoxyribonucleic acid (DNA) transfer.
Results: This work reports the development of an electrotransformation protocol permitting high-level DNA
transfer to C. pasteurianum ATCC 6013 together with accompanying selection markers and vector components. The
CpaAI restriction-modification system was found to be a major barrier to DNA delivery into C. pasteurianum which
we overcame by in vivo methylation of the recognition site (5’-CGCG-3’) using the M.FnuDII methyltransferase. With
proper selection of the replication origin and antibiotic-resistance marker, we initially electroporated methylated
DNA into C. pasteurianum at a low efficiency of 2.4 × 101 transformants μg-1 DNA by utilizing conditions common
to other clostridial electroporations. Systematic investigation of various parameters involved in the cell growth,
washing and pulse delivery, and outgrowth phases of the electrotransformation procedure significantly elevated the
electrotransformation efficiency, up to 7.5 × 104 transformants μg-1 DNA, an increase of approximately three order
of magnitude. Key factors affecting the electrotransformation efficiency include cell-wall-weakening using glycine,
ethanol-mediated membrane solubilization, field strength of the electric pulse, and sucrose osmoprotection.
Conclusions: C. pasteurianum ATCC 6013 can be electrotransformed at a high efficiency using appropriately
methylated plasmid DNA. The electrotransformation method and tools reported here should promote extensive
genetic manipulation and metabolic engineering of this biotechnologically important bacterium.
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As a promising high-energy biofuel and bulk chemical,
butanol is produced fermentatively by select members of
the genus Clostridium [1]. Recent efforts to reinstate an
economical fermentation-based butanol industry able to
rival current petrochemical production routes have thus
far proven uncompetitive [2]. Restrictive feedstock cost,
accounting for up to 80% of total biobutanol production
[3,4], is often regarded as the chief factor limiting
industrialization. Advantageously, tremendous expansion
experienced by the global biodiesel industry in recent
years has led to a significant oversupply of crude gly-
cerol, which is generated as a waste stream representing
approximately 10% (w/w) of the unpurified biodiesel
product [5-7]. In analogy to the biodiesel industry,
immense rise in global bioethanol production has led to
the accumulation of thin stillage, the aqueous fraction of
whole stillage and an inexpensive waste product possessing
a high proportion of unpurified, fermentable glycerol [8].
Accordingly, glycerol has become a highly attractive
fermentable substrate due to its low cost and high degree
of reduction.
Despite the notoriously wide substrate utilization range
exhibited by the clostridia for butanol production, few
species are able to grow on glycerol as a sole carbon and
energy source. The prototypical industrial butanol pro-
ducers, Clostridium acetobutylicum and C. beijerinckii,
can only metabolize glycerol if the growth medium is
supplemented with a less reduced carbon source, such as
glucose [9], thus devaluing the economic advantages
afforded by waste glycerol feedstocks. Though C.
butyricum can ferment glycerol without glucose supple-
mentation, it does not express a functional butanol
biosynthetic pathway [10]. Among the clostridia, C.
pasteurianum appears to be the only species that com-
bines the capacity for glycerol dissimilation with a highly
active butanol-producing pathway [11]. Under proper
conditions for cultivation of C. pasteurianum using
glycerol, butanol, ethanol, and 1,3-propanediol dominate,
while organic acids are produced in only trace amounts
[12]. Numerous recent studies have investigated the
fermentation of pure and crude glycerol [10,12-17], in
addition to thin stillage [18], by C. pasteurianum.
Unlike the past industrial workhorses, C. acetobutylicum
and C. beijerinckii, C. pasteurianum has garnered nominal
attention as a potential host for the production of butanol.
This is largely due to the current inability to transfer DNA
to C. pasteurianum, in addition to lack of a genome
sequence for this organism. Based on early genetic studies,
it appears efforts were in place to conduct genetic
manipulation of C. pasteurianum, since a method for pro-
ducing and regenerating protoplasts was developed [19]
and a Type-II restriction endonuclease was identified as
a potential barrier to gene transfer [20]. Successfulconjugation-based plasmid transfer to C. pasteurianum
has also been documented [20], yet no protocol has been
described, nor have any genetic mutants arisen from this
work. Accordingly, no genetic tools are currently available
for the manipulation of C. pasteurianum. Recent efforts to
improve C. pasteurianum butanol production have fo-
cused on traditional and less favorable random chemical
mutagenesis techniques [21,22]. In order to construct su-
perior C. pasteurianum strains through rational genetic and
metabolic engineering strategies, it is pertinent to develop
methods to transfer foreign DNA to this microorganism.
In contrast to Gram-negative bacteria, Gram-positive
cells possess an extensive exterior network of peptido-
glycan which physically restricts passage of exogenous
DNA into the cell. For this reason, electrotransformation
of Gram-positive species is generally less efficient than
Gram-negative strains [23]. To overcome the thick
Gram-positive cell wall, mild or brief pretreatment using
cell-wall-weakening agents, such as lysozyme, glycine,
DL-threonine, or penicillin G, is commonly required to
achieve optimal electrotransformation while maintaining
sufficient cell viability [23,24]. Whereas some species of
Clostridium can be electrotransformed without the use
of cell-wall-weakening agents [25,26], others are
electrotransformed at elevated levels when treated with
such additives [27-29]. Poor electrotransformation effi-
ciency of Gram-positive bacteria is further compounded
within the clostridia due to the unusually high produc-
tion of non-specific cell-wall-associated nucleases [26].
A number of highly-specific clostridial Type-II restric-
tion endonucleases have also been identified [25,26,30],
including CpaAI from C. pasteurianum ATCC 6013
[20], highlighting the importance of DNA protection via
methylation of the transforming DNA. Unidentified
restriction-modification systems are likely the underlying
cause of electrotransformation recalcitrance that has been
observed with certain species, such as C. butyricum [31].
In summary, development of electrotransformation within
the clostridia entails investigation of cell-wall-weakening
additives, inactivation or evasion of non-specific nucle-
ases, and protection of foreign DNA against highly spe-
cific restriction endonucleases, in addition to examination
of other common parameters involved in the cell growth,
washing and pulse delivery, and recovery phases of the
standard bacterial electrotransformation procedure [23,24].
As an entry point to allow genetic manipulation of C.
pasteurianum, here we report the development of an
electroporation-mediated transformation system for C.
pasteurianum ATCC 6013. CpaAI was validated as a
major restriction endonuclease attacking foreign DNA
delivered into C. pasteurianum and this mechanistic
limitation was resolved by in vivo methylation of the
recognition site (5’-CGCG-3’) prior to electroporation.
Methylation alone, however, did not result in high-level
Pyne et al. Biotechnology for Biofuels 2013, 6:50 Page 3 of 20
http://www.biotechnologyforbiofuels.com/content/6/1/50transfer of DNA into C. pasteurianum. Instead, through
systematic investigation, we developed an efficient
electrotransformation method that is dependent on weak-
ening of the cell wall using glycine, ethanol-mediated
membrane solubilization, a low electric field, and osmotic
stabilization afforded by sucrose. In addition to the elec-
troporation protocol, we also identified effective antibiotic
selection systems and origins of replication capable of sus-
taining plasmids in C. pasteurianum. To our knowledge,
this study presents the first demonstration of DNA trans-
fer into C. pasteurianum with a high efficiency and opens
an avenue for extensive genetic and metabolic engineering
of C. pasteurianum.
Results
Protection of plasmid DNA from CpaAI restriction
To develop a C. pasteurianum transformation protocol,
we first assayed crude cell lysates for the presence of
restriction-modification systems, which potently inhibit
plasmid DNA transfer to bacteria. At least one Type-II
restriction endonuclease, designated CpaAI with 5’-
CGCG-3’ recognition and an isoschizomer of ThaI and
FnuDII, has been previously identified in cell-free lysates
of C. pasteurianum ATCC 6013 [20]. We initially pre-
pared crude cell lysates through sonication of whole cells.
As found in other species, such as C. acetobutylicum
[26,32], lysates generated in this manner potently de-
graded all plasmid DNA substrates, presumably due to
non-specific cell-wall-associated nucleases (data not
shown). To overcome non-specific nuclease activity, we
then aimed to assay CpaAI restriction activity using
protoplast extracts, which allowed clear detection of
CpaAI activity. Optimal digestion occurred between 2–
4 hours incubation at 37°C and produced a restriction
pattern identical to that of BstUI, a commercial
isoschizomer of CpaAI (Figure 1A). Since all known
BstUI isoschizomers catalogued in REBASE [33] are
sensitive to methylation of both external cytosine resi-
dues within the 5’-CGCG-3’ recognition sequence, we
next assessed the effect of external cytosine methylation
by expression of the M.FnuDII methyltransferase (with
5’-mCGCG-3’ methylation site of both DNA strands)
from plasmid pFnuDIIMKn. M.FnuDII methylation
protected pMTL85141, an E. coli-Clostridium shuttle
vector [34], from degradation by CpaAI and BstUI
(Figure 1B). While unmethylated substrates were sig-
nificantly restricted after 2 hours incubation at 37°C,
M.FnuDII-methylated substrates were completely re-
sistant to cleavage, even after 8 h. Note that methylated
pMTL85141 plasmid preparations, which also contains
the pFnuDIIMKn methylating plasmid, migrated at a
different molecular weight than unmethylated plasmid
preparations. However, when we linearized the double-
plasmid preparation, in addition to preparations of the twoindividual plasmids, we observed no detectable changes in
plasmid size or unexpected products (Figure 1B, right
panel). In vitro methylation with commercial M.SssI
(5’-mCG-3’ methylation site) and M.CviPI (5’-GmC-3’
methylation site) methyltransferases also protected plas-
mids from digestion by CpaAI in protoplast extracts and
commercial BstUI (not shown).
Initial electrotransformation of C. pasteurianum
To electrotransform C. pasteurianum, we employed a
series of E. coli-Clostridium shuttle vectors which differ
only in their Gram-positive origins of replication:
pMTL82151 (pBP1 ori from C. botulinum); pMTL83151
(pCB102 ori from C. butyricum); pMTL84151 (pCD6 ori
from C. difficile); and pMTL85141 (pIM13 ori from Bacil-
lus subtilis) [34]. We utilized conditions common to
clostridial electrotransformation procedures (Table 1) and
M.FnuDII-methylated DNA. Of the four vectors tested,
pMTL83151, pMTL84151, and pMTL85141 yielded
colonies using thiamphenicol selection, corresponding to
electrotransformation efficiencies of 0.7 × 101, 0.3 × 101,
and 2.4 × 101 transformants μg-1 DNA, respectively. Ac-
cordingly, pMTL85141 was selected as the vector used for
all subsequent electrotransformation work. Importantly,
no transformants were obtained with unmethylated plas-
mid, validating the necessity to protect transforming DNA
against the endogenous CpaAI restriction endonuclease.
Interestingly, while in vivo methylation was essential for
transformation, we did not obtain transformants when
pMTL85141 was methylated in vitro with M.SssI or M.
CviPI methyltransferases, although both enzymes protect
pMTL85141 from digestion by CpaAI. This result is unex-
pected, but is speculated upon later in this report.
To confirm the presence of pMTL85141 in transformed
colonies, we screened thiamphenicol-resistant colonies for
the presence of the catP resistance marker within
pMTL85141 using colony PCR (Figure 2A). All of the col-
onies screened generated a single expected product of
518 bp. To further confirm the presence of plasmid and de-
termine if rearrangements or recombinations occurred
upon transfer to C. pasteurianum, plasmid pMTL85141was
isolated and purified from thiamphenicol-resistant colonies
and digested with XhoI. XhoI digestion of all plasmid prep-
arations from C. pasteurianum yielded a single band on a
1.0% agarose gel, similar to the digestion of pMTL85141
prepared from E. coli DH5α (Figure 2B). The presence of
the methyltransferase vector, pFnuDIIMKn, could not be
detected in C. pasteurianum plasmid preparations.
High-level electrotransformation of C. pasteurianum
An electrotransformation efficiency of 2.4 × 101
transformants μg-1 DNA is very low relative to the effi-
ciency of other clostridia (i.e., up to 106 transformants















Figure 1 M.FnuDII methyltransferase-mediated protection of pMTL85141 against CpaAI endonuclease. A. Time course digestion of
pMTL85141 using crude protoplast extracts possessing CpaAI restriction activity, resolved on a 2% agarose gel. Digestion reactions contained
1.0 μg pMTL85141 and 25% protoplast extract in a total volume of 20 μl 1× CpaAI custom buffer. For comparison, pMTL85141 is shown
undigested and digested with BstUI, a commercial isoschizomer of CpaAI. Expected digestion products are 1785, 581, 270, 252, and 75 bp. B. M.
FnuDII-mediated protection of pMTL85141 from CpaAI digestion (left panel). Protoplast extract digestions contained 1.0 μg pMTL85141 or
pMTL85141+pFnuDIIMKn, the vector harboring the M.FnuDII methyltransferase gene, and 25% protoplast extract in a total volume of 20 μl 1×
CpaAI custom buffer. pMTL85141 preparation in the presence of plasmid pFnuDIIMKn afforded protection of pMTL85141 from both BstUI and
CpaAI restriction, as no digestion products could be detected. Methylation treatment resulted in the presence of high-molecular weight bands.
Linearization of the high molecular weight bands by NcoI digestion (right panel) confirmed the presence of pMTL85141 (2,963 bp) and the
methylating plasmid, pFnuDIIMKn (6,449 bp), at the correct sizes of the individual linearized vectors.
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Therefore, we were prompted to develop a high-level
electrotransformation protocol by systematically investi-
gating the effects on electrotransformation efficiency of pa-
rameters throughout all phases of the electrotransformation
procedure. Electrotransformation efficiencies reported below
represent the average of at least two electrotransformation
experiments using the same preparation of electrocompetent
cells.
(i) Cell-wall-weakening. We first investigated the use of
cell-wall-weakening agents due to their potential togreatly enhance electrotransformation by weakening
of the Gram-positive cell wall [24]. A screening
experiment was conducted to identify potential
additives capable of enhancing electrotransformation
of C. pasteurianum, including glycine, DL-threonine,
lysozyme, and penicillin G (Figure 3A). Individually,
we screened the effect of glycine and DL-threonine
by supplying the additives in the presence of 0.25 M
sucrose at the first signs of growth (OD600 of
0.3-0.4) because cultures failed to grow to sufficient
cell densities if glycine or DL-threonine were present
without sucrose supplementation or if the additives
Table 1 Consensus clostridial electrotransformation conditions leading to initial low-level transformation of C. pasteurianum
Electrotransformation parameter Consensus for Clostridium species Low-level transformation of C. pasteurianum Selected references
Cell growth
Growth medium YTG or 2×YTG 2×YTG [44,58,59]
Growth phase and OD600 at time
of harvest
mid to late exponential phase (OD600 0.5–0.9) OD600 0.6-0.8 [25]
Washing and pulse delivery
Wash and electroporation buffer 5–7 mM sodium phosphate, pH 6.5-7.4, containing 270 mM sucrose
and 1 mM MgCl2
5 mM sodium phosphate, pH 6.5, containing 270 mM sucrose
and 1 mM MgCl2
[25,26,29]
Number of wash steps 1 1 [44,45,58]
Cuvette gap width 0.4 cm 0.4 cm [29,45,46]
Volume of cells 600 μl 600 μl [26]
Pulse parameters 2.0–2.5 kV; 25 μF; 200–800 Ω; 4–8 ms 2.0–2.5 kV; 25 μF; 200–800 Ω; 6–9 ms [44,46]
Outgrowth
Recovery and plating medium YTG or 2×YTG 2×YTG [58,59]



























Figure 2 Low-level electrotransformation of C. pasteurianum. A. Colony PCR confirmation of pMTL85141 presence in C. pasteurianum
transformants using primers pMTL.seq.S and pMTL.seq.AS. The expected product of 518 bp could only be amplified from E. coli transformed with
pMTL85141 and from thiamphenicol-resistant C. pasteurianum colonies, and not from non-recombinant [66] C. pasteurianum. B. XhoI-linearized
pMTL85141 plasmid prepared from E. coli DH5α and from a representative transformant of C. pasteurianum showing the expected plasmid size of
2,963 bp. Some undigested vector remains visible in the E. coli preparation.
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rate was slightly reduced in the presence of both
glycine and DL-threonine. On the other hand,
lysozyme and penicillin G were screened by addition
at the wash stage in the wash and electroporation
buffer, followed by incubation at 37°C for
30 minutes prior to electroporation. Additive
concentrations were chosen based on previous
electrotransformation studies with various species of
Gram-positive bacteria [29,36-39]. Of the four
additives screened, only glycine and DL-threonine
improved the electrotransformation efficiency. The
samples treated with 40 μg/ml lysozyme and 30 μg/
ml penicillin G even failed to grow during the
outgrowth period following electroporation,
potentially due to cell lysis. Despite a slight
inhibition on cell growth, more than 7-fold
enhancement of electrotransformation efficiency
was attained using 1.5% glycine, compared to the
control experiment with no cell-wall-weakening
agent. Supplementation of 20 and 40 mMDL-threonine provided approximately 1.6- and 2.1-
fold increases, respectively, in electrotransformation
efficiency. Although glycine and DL-threonine have
different mechanisms of cell wall disruption,
combining glycine and DL-threonine treatments
did not lead to a synergistic increase in
electrotransformation efficiency.
As a result of the clear benefit of glycine on the
electrotransformation efficiency, we set out to
determine the optimum glycine regimen with
respect to concentration and duration of exposure.
This investigation was done concomitant with
investigating the effect of sucrose on
electrotransformation efficiency by providing
osmoprotection during the various cell-wall-
weakening glycine treatments. We tested glycine at
0.75, 1.0, and 1.25% in the presence of either 0.25
or 0.4 M sucrose, corresponding to nearly isotonic
and hypertonic extracellular environments,
respectively. The highest glycine concentration was
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Sucrose concentration - Recovery medium
Figure 3 (See legend on next page.)
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Figure 3 Investigation of cell-wall-weakening and osmoprotection on electrotransformation of C. pasteurianum. A. Investigation of cell-
wall-weakening agents. Cells were grown to early exponential phase (OD600 0.3-0.4) and glycine (gly) or DL-threonine (thr) was added along with
0.25 M sucrose (suc). For lysozyme and penicillin G treatments, additives were supplemented to buffer SMP prior to electroporation and
incubated anaerobically at 37°C for 30 minutes. An untreated culture was included as a control. The OD600 of each culture at time of harvest is
shown (ο). Pulse duration was unaffected between samples. B. Investigation of glycine and sucrose concentrations. Six cultures were grown to an
OD600 of 0.4 and glycine was added to a final concentration of 0.75, 1.0, or 1.25% together with sucrose at 0.25 (light shading) or 0.4 M (dark
shading). Growth was minimally affected between samples, as all cultures attained a final OD600 of 1.2-1.5. Pulse duration was unaffected
between samples. C. Investigation of glycine concentration and duration of exposure. Two cultures were grown to an OD600 of 0.4 and glycine
was added to a final concentration of 0.75 or 1.25% together with 0.4 M sucrose. An additional control culture was prepared without either
glycine or sucrose supplementation. Cells were harvested, washed, and electroporated at either 2.5 (light shading) or 4 hours (dark shading)
following supplementation with glycine and sucrose. Pulse duration was unaffected between samples. D. Effect of sucrose concentration within
the wash and electroporation buffer. Cultures were washed and electroporated in SMP buffer containing either isotonic (0.27 M) or hypertonic
sucrose (0.5 M). Pulse duration was unaffected between samples. E. Effect of sucrose concentration within the outgrowth medium. Cultures were
electroporated and resuspended and grown in 2×YTG medium containing either 0.2 or 0.4 M sucrose.
Pyne et al. Biotechnology for Biofuels 2013, 6:50 Page 8 of 20
http://www.biotechnologyforbiofuels.com/content/6/1/50which becomes significant at concentrations equal
to or greater than 1.5%. Increasing the sucrose
concentration from 0.25 to 0.4 M led to a
significant increase in electrotransformation
efficiency under all glycine concentrations tested
(Figure 3B). To examine the effect of the duration
of glycine exposure on electrotransformation
efficiency, cultures were incubated with 0, 0.75, or
1.25% glycine in the presence of 0.4 M sucrose
starting at an OD600 of 0.4 for either 2.5 or
4.5 hours prior to washing and pulse delivery
(Figure 3C). Maximum electrotransformation
efficiency was attained by exposing cells to 1.25%
glycine for 2.5 hours in the presence of 0.4 M
sucrose, a 10.7-fold increase compared to the
untreated control culture. Interestingly, lower
glycine concentrations could be compensated for
by increasing the duration of exposure. When
using a glycine concentration of 0.75% in the
growth medium, 4.5 hours rather than 2.5 hours of
exposure generated a greater electrotransformation
efficiency at this lower glycine concentration,
although the absolute gain in electrotransformation
efficiency was still lower than with 1.25% glycine.
(ii) Osmoprotection. We continued to investigate the
effect of the osmoprotectant concentration on
electrotransformation efficiency during the
subsequent washing and electroporation phase and
the outgrowth phase following electroporation.
Cells grown in the presence of 1.25% glycine and
0.4 M sucrose were washed and electroporated in
the common clostridial SMP buffer containing
either 0.27 M (isotonic) or 0.5 M (hypertonic)
sucrose (Figure 3D). SMP buffer outperformed
other buffers tested, such as 10% PEG 8000, 15%
glycerol, protoplast buffer with lysozyme omitted,
and SMP buffer supplemented with 15% glycerol
(data not shown). Hypertonic sucrose, which
improved the electrotransformation efficiencywhen included during the growth phase, reduced
electrotransformation efficiency by a factor of 10.3
when included at the washing and electroporation
phase. Thus, 0.27 M sucrose was adopted as the
optimum sucrose concentration in the wash and
electroporation buffer.
To assess the effect of sucrose osmoprotection
during cell recovery immediately following delivery
of the electric pulse, cells were grown, made
electrocompetent, pulsed, and resuspended in
10 ml 2×YTG containing either 0.2 or 0.4 M
sucrose (Figure 3E). Similar to the washing and
electroporation phase, hypertonic sucrose again
reduced electrotransformation efficiency, although
the effect was modest (a 1.1-fold decrease), and
thus, 0.2 M was adopted as the optimum sucrose
concentration in the outgrowth medium.
(iii) Cell membrane solubilization. After developing a
regimen to weaken the exterior cell wall while
supporting cell viability with sucrose
osmoprotection, we next sought to enhance transfer
of plasmid DNA to C. pasteurianum with the use of
ethanol to solubilize the cell membrane, a strategy
which has proved effective with some species of
Gram-negative bacteria [40,41]. We also extended
this approach to butanol, which elicits a more
pronounced toxic effect on cells. To achieve
maximum membrane solubilization without
adversely affecting cell viability, we utilized
concentrations near the toxicity threshold for many
species of Clostridium, which were up to 15% (v/v)
for ethanol and 2% (v/v) for butanol [42,43]. Five
minutes prior to electroporation, ethanol or butanol
was added directly to the cell-DNA suspension.
Ethanol added at 5 and 10% provided a 1.6- and
1.3-fold respective increase in electrotransformation
efficiency, compared to the control experiment with
no ethanol treatment (Figure 4). Butanol, and














































Cell Membrane Solubilization Additive
Figure 4 Investigation of membrane permeabilization on the electrotransformation of C. pasteurianum. Immediately prior to pulse
delivery, cell-DNA suspensions were supplemented with 5, 10, or 15% ethanol (EtOH) or 1 or 2% butanol (BuOH). An untreated sample was included
as a control. The time constant of each pulse is shown (ο). The sample treated with 2% butanol failed to grow during the allotted 16-hour recovery
period following electroporation.
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butanol sample grew extremely slowly during the
outgrowth period following electroporation. The
addition of ethanol increased the pulse time
constant, which may have influenced
electrotransformation efficiency (Figure 4). Butanol
did not significantly affect the pulse time constant.
(iv) Electric pulse parameters. We investigated the
effects of the electrical pulse with respect to
voltage (i.e., field strength), capacitance, and
resistance (Figure 5A-C). In an initial screening
experiment, low voltages in the range of 1.8-2.0 kV
generated significantly more transformants than
voltages of 2.0-2.5 kV (data not shown), which are
representative of most electrotransformation
protocols using species of Clostridium [29,44-46].
Hence, pulses of 1.6, 1.8, and 2.0 kV were
administered, corresponding to field strengths of
4.0, 4.5, and 5.0 kV cm-1 (Figure 5A), using a
capacitance of 25 μF and a resistance of ∞ Ω
(i.e., without the use of Pulse Controller module).
A voltage of 1.8 kV was found to produce the
greatest electrotransformation efficiency, although
pulses of 1.6 and 2.0 kV only slightly reduced the
electrotransformation efficiency. Pulse duration
decreased by approximately 1 ms when increasing
pulse voltage from 1.6 to 1.8 kV and from 1.8 to
2.0 kV. Next, capacitances of 25 and 50 μF were
assessed at voltages of 1.8 and 2.25 kV, and ∞ Ω
(Figure 5B). At both voltages, increasing the
capacitance from 25 to 50 μF reducedelectrotransformation efficiency by a factor of 2.7
(1.8 kV) and 15.6 (2.25 kV), respectively. Similarly,
decreasing resistance from ∞ Ω to 200 and 600 Ω,
at 2.25 kV and 25 μF was unproductive and
resulted in a 3.3- and 2.3-fold decrease in
electrotransformation efficiency, respectively
(Figure 5C). Pulse duration changes were not
predictive of the effects on electrotransformation
efficiency, as increases in the time constant
accompanying changes in capacitance and
decreases in the time constant accompanying
changes in resistance both correlated with
decreased electrotransformation efficiency.
(v) DNA quantity and outgrowth duration. Finally, we
evaluated the effect of DNA amount on both
number of transformants and electrotransformation
efficiency (Figure 6A) and the effect of the duration
of outgrowth following electroporation. Although
the total number of transformants was found to
increase linearly between 0.5 and 5.0 μg of
pMTL85141, the greatest electrotransformation
efficiency occurred using 0.5 μg of plasmid DNA.
Transformants could be detected at the lowest
quantity of DNA tested, 0.25 μg, and saturation with
pMTL85141 was not observed up to 5.0 μg, the
highest quantity of DNA tested.
For assessing outgrowth duration, we incubated
electroporated cells for 0, 2, 4, 6, or 16 hours prior to plat-
ing on selective medium. Growth in the form of gas for-
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Figure 5 Investigation of electric pulse parameters on the electrotransformation of C. pasteurianum. A. Effect of pulse voltage (field
strength). Electrotransformation efficiency was measured using electric pulses of 1.6, 1.8, or 2.0 kV, corresponding to field strengths of 4.0, 4.5, and
5.0 kV cm-1. The time constant of each pulse is shown (ο). B. Effect of pulse capacitance. Electrotransformation efficiency was measured at 25
(light shading) and 50 μF (dark shading) under voltages of 1.8 and 2.25 kV. The time constant of each pulse is shown (ο). C. Effect of pulse resistance.
Electrotransformation efficiency was measured at 200, 600, and ∞ Ω at a voltage of 2.25 kV. The time constant of each pulse is shown (ο).















































































Figure 6 Investigation of amount of DNA and outgrowth duration on the electrotransformation of C. pasteurianum. A. Effect of plasmid
DNA amount on total number of transformants and electrotransformation efficiency of C. pasteurianum. Separately, 0, 0.25, 0.5, 1.0, 2.5, and 5.0 μg of
pMTL85141 were added to electrocompetent cells of C. pasteurianum and electroporated. Total number of thiamphenicol-resistant transformants (light
shading) and electrotransformation efficiency (dark shading) were quantified. Pulse duration was unaffected between samples. Zero μg pMTL85141
failed to generate thiamphenicol-resistant transformants. B. Effect of post-electroporation incubation time. Cells were electroporated, transferred to
10 ml outgrowth medium containing 0.2 M sucrose, and incubated for 0, 2, 4, 6, or 16 hours prior to selective plating.
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medium. Transformants could be obtained without re-
covery (i.e., 0 hours incubation), although at a signifi-
cantly reduced efficiency (7.9- to 12.1-fold reduction
compared to 2–16 hours incubation) (Figure 6B). As
expected, the greatest electrotransformation efficiency
was attained using the longest recovery time tested (i.e.,
16 hours), which was approximately 1.3-fold greater
than at 4–6 hours outgrowth, during which time theelectrotransformation efficiency was unchanged. While
16 hours of outgrowth is a convenient duration due to
the length of the pre-growth and washing and electro-
poration phases, electrotransformation efficiency for
clostridia is typically reported following 4–6 hours of
outgrowth. Thus, the electrotransformation efficiencies
reported here, all of which involved 16 hour outgrowth
experiments, can be divided by 1.3 for comparision to
other clostridial electroporation efficiencies.
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other vectors
Since many clostridial vectors favor the ermB determinant
for erythromycin or clarithromycin selection, rather than
catP-based thiamphenicol selection used in this study, we
constructed pMTL85141ermB, a dual catP and ermB select-
able plasmid. Comparable, high-level electrotransformation
efficiencies (1.0-1.4 × 104 transformants μg-1 DNA) were
obtained by selection of pMTL85141ermB using 15 μg/ml
thiamphenicol, 4 μg/ml clarithromycin, or 20 μg/ml erythro-
mycin. Control plasmid transformations lacking the
ermB determinant failed to generate clarithromycin- or
erythromycin-resistant colonies. Therefore, ermB-based
clarithromycin or erythromycin selection is effective
using C. pasteurianum.
To determine the generality of our high-efficiency
electrotransformation protocol for other vectors, we also
attempted electrotransfer of pSY6catP into C. pasteurianum.
pSY6catP is a modified form of pSY6 [47] whereby the ermB
erythromycin-resistance determinant is replaced with catP
from pMTL85141. pSY6 is one of several E. coli-Clostridium
shuttle vectors (in addition to, e.g., the ClosTron system of
vectors [48]), which harbours the Ll.ltrB group II intron
machinery necessary for performing intron-mediated
gene knockouts in clostridia. A pSY6-based vector was
chosen because it possesses the same pIM13 replicon
as pMTL85141, thereby eliminating potential variation in
efficiency due to differences in the origin of replication.
Unexpectedly, pSY6catP transformed C. pasteurianum at a
significantly decreased efficiency of 1.1 × 101 transformants
μg-1 DNA, an efficiency approximately 1,000-fold lower
than achieved with pMTL85141. To rule out a vector size
effect on the reduction in electrotransformation efficiency
(pSY6catP is 8,498 bp, whereas pMTL85141 is 2,963 bp),
we also attempted to transform pHT3, a 7,377 bp vector
with the same fundamental vector components as
pMTL85141ermB, in addition to a heterologous lacZ gene
from Thermoanaerobacterium thermosulfurogenes EM1
[49] (Table 2). Unlike pSY6catP, pHT3 transformed at a
high efficiency of 1.8 × 104 transformants μg-1 DNA, which
is comparable to pMTL85141ermB. Therefore, the dra-
matic reduction in electrotransformation efficiency is likely
not due to differences in plasmid size. At this point, we
hypothesize the presence of an additional unidentified re-
striction system which targets certain common site(s) of
pSY6catP, but not pMTL85141, pMTL85141ermB, or
pHT3, much like the dcm-methylation-dependent restric-
tion systems recently addressed in C. thermocellum and C.
ljungdahlii [27,50]. Our observation of the transformability
of in-vivo-methylated plasmids, but not in-vitro-methylated
plasmids, may also be the result of an unidentified
methylation-dependent restriction system, which may or
may not be the same one affecting pSY6catP. The in vitro
M.SssI and M.CviPI methyltransferases we utilized, with5’-mCG-3’ and 5’-GmC-3’ methylation sites, respectively,
each methylate a larger number of sites than the M.FnuDII
in vivo methyltransferase (5’-mCGCG-3’ methylation site).
Since certain DNA substrates containing 5-methylcytosine
are restricted, it is likely that over-methylated pMTL85141
could be unexpectedly targeted by a Type II or Type IV 5-
methylcytosine-specific restriction endonuclease in C.
pasteurianum. Experiments are underway to probe for an
additional restriction system in C. pasteurianum. Nonethe-
less, even with the reduced electrotransformation efficiency
of pSY6catP, we have used it to successfully introduce type
II introns into the C. pasteurianum genome in preliminary
experiments (data not shown), whereas this was not pos-
sible with the low-level electrotransformation efficiency we
initially obtained prior to our electrotransformation studies
detailed in this report.
Discussion
Lack of a gene transfer system has fundamentally hindered
genetic manipulation of C. pasteurianum. We report here
the first development of an electroporation-mediated pro-
cedure for high-level gene transfer to C. pasteurianum.
The first step in overcoming this barrier involved
confirming the previously identified C. pasteurianum re-
striction endonuclease, CpaAI, which cleaves 5’-CGCG-3’
nucleotide sequences. In vivo methylation using the M.
FnuDII methyltransferase allowed protection of E. coli-C.
pasteurianum shuttle vectors. Active protoplast extracts
of C. pasteurianum completely degraded pMTL85141
prepared from E. coli DH5α, but not when prepared
from E. coli ER1821 harboring both pMTL85141 and
pFnuDIIMKn (Figure 1A, B). This finding allowed us to
demonstrate low-level electrotransformation of C.
pasteurianum by using conditions commonly utilized
for clostridial electroporation (Table 1). Despite re-
peated attempts, unmethylated pMTL85141 (i.e., prepared
from E. coli DH5α in the absence of plasmid pFnuDIIMKn)
was unable to transform C. pasteurianum, confirming the
requirement for proper methylation of plasmid DNA prior
to electrotransformation. Plasmid transfer was confirmed
through colony-PCR-amplification, isolation and purifica-
tion, and DNA sequencing of plasmid pMTL85141 from
thiamphenicol-resistant colonies (Figure 2A, B; data
not shown). The resulting plasmid preparation from C.
pasteurianum was devoid of rearrangements and
recombination and could only transform restriction-
deficient strains of E. coli, such as ER1821. The initial effi-
ciency of approximately 2.4 × 101 transformants μg-1
DNA paled in comparison to electrotransformation levels
achieved with other species of Clostridium (up to 106
transformants μg-1 DNA [35]) and prevented transfer
of low-level-transforming vectors, such as pSY6catP
(discussed below). Thus, we investigated the effects of
several parameters critical for the electrotransformation
Table 2 Strains, plasmids, and oligonucleotides
Strain Relevant characteristics Source or reference
Escherichia coli DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK-mK+), λ- Lab stock




Wild-type American Type Culture
Collection
Plasmid Relevant characteristics Source or reference
pET-20b(+) E. coli pET-series expression vector (ApR; ColE1 ori) Novagen
pETKnFRT Derived by inserting the FRT-flanked kan gene of pKD4 into the MCS of pET-20b(+) (ApR; ColE1 ori; FRT-KnR-FRT) This study
pFnuDIIM The M.FnuDII methyltransferase gene of Fusobacterium nucleatum inserted into the tet gene of pACYC184 (p15A ori; CmR) [65]
pFnuDIIMKn Derived by inserting the FRT-flanked kan gene of pETKnFRT into the cat gene of pFnuDIIM (p15A ori; KnR) This study
pHT3 E. coli-C. pasteurianum shuttle vector containing lacZ from Thermoanaerobacterium thermosulfurogenes EM1 (ApR; ColE1 ori; ErmR; pIM13 ori) [49]
pIMP1 E. coli-C. pasteurianum shuttle vector (ApR; ColE1 ori; ErmR; pIM13 ori) [26]
pKD4 Template vector (ApR; pR6K ori; FRT-KnR-FRT) [70]
pMTL82151 E. coli-C. pasteurianum shuttle vector (CmR; ColE1 ori; pBP1 ori) [34]
pMTL83151 E. coli-C. pasteurianum shuttle vector (CmR; ColE1 ori; pCB102 ori) [34]
pMTL84151 E. coli-C. pasteurianum shuttle vector (CmR; ColE1 ori; pCD6 ori) [34]
pMTL85141 E. coli-C. pasteurianum shuttle vector (CmR; ColE1 ori; pIM13 ori) [34]
pMTL85141ermB Derived by insertion of the ermB gene of pIMP1 into pMTL85141 This study
pSC12 E. coli-C. pasteurianum shuttle vector (CmR; ColE1 ori; pIM13 ori) [66]
pSY6 E. coli-C. pasteurianum expression vector carrying the L. lactis ltrB group II intron under control of the C. acetobutylicum ptb promoter, and
ltrA ORF (ApR; ColE1 ori; ErmR; pIM13 ori)
[47]
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were able to elevate the electrotransformation efficiency to
a maximum of 7.5 × 104 transformants μg-1 DNA, an in-
crease of more than three orders of magnitude from the
original low-level electrotransformation efficiency (Table 3).
The electroporation parameters determined to be most in-
fluential on the electrotransformation of C. pasteurianum
are discussed in detail below.
Gram-positive bacteria are electrotransformed at effi-
ciencies several orders of magnitude lower than Gram-
negative cells, highlighting the importance of effective
weakening of the Gram-positive cell wall prior to elec-
troporation. The most widely used additives for this pur-
pose are glycine, DL-threonine, lysozyme, and penicillin
G, all of which were screened in this study (Figure 3A).
Under the conditions tested, only glycine and DL-threo-
nine afforded enhanced levels of electrotransformation,
with glycine rendering the cell most susceptible to
electrotransformation. Glycine has been widely used for
increasing electrotransformation efficiency of Gram-
positive bacteria [36,37,39,51-56] and its mode of action
has been extensively studied [57]. Specifically, glycine is
incorporated into the peptidoglycan network through
replacement of critical D- and L-alanine residues, gener-
ating a weakened cell wall due to a lesser degree of
cross-linking [57]. To balance glycine supplementation
with cell viability, we determined that optimum electro-
poration is achieved using brief exposure to the highest gly-
cine concentration that still permits sufficient cell growth.
The optimized glycine regimen for C. pasteurianum in-
volves exposure of early exponential phase cells to 1.25%
glycine for 2–3 hours (Figure 3B, C), which is most similar
to protocols developed for Mycobacterium avium [37],Table 3 Summary of protocol for high-level electrotransforma
level protocol




OD600 at time of harvest OD600 0.6-0.8
Washing and pulse delivery
Osmotic stabilizer Isotonic sucrose (0.27 M)
Cell membrane solubilizer None
DNA amount 5 μg
Pulse parameters 2.0-2.5 kV; 25 μF; 200–800 Ω
Outgrowth
Osmotic stabilizer None
Recovery time 16 h
Transformation efficiency 2.4 × 101 transformants μg-1Bacillus subtilis [54], and B. thuringiensis [55]. Of particu-
lar importance is the timing of glycine addition. Specific-
ally, glycine should be added only when the cells enter the
exponential growth phase, as glycine supplementation at
the time of inoculation resulted in significant growth inhib-
ition. While cell-wall-weakening is not an indispensable re-
quirement for electrotransformation of C. pasteurianum, a
significant increase in electrotransformation efficiency was
obtained with glycine treatment. To our knowledge this
study represents the first use of glycine as a cell-wall-weak-
ening and electroporation-enhancing agent within the Clos-
tridium genus.
Upon treatment with glycine, cells possess a
compromised cell wall, and therefore, it is paramount
that cells be stabilized osmotically. Our results clearly
demonstrate the importance of sucrose osmoprotection
during glycine treatment, as cultures without sucrose
supplementation failed to grow in the presence of
glycine. Although 0.25 M sucrose in the growth medium
was sufficient to promote growth, increasing the concen-
tration to 0.4 M afforded a significant enhancement to
electrotransformation (Figure 3B). In opposition to the
growth medium, however, hypertonic sucrose in the re-
covery medium (0.4 M) was found to have a slightly
negative effect on electrotransformation efficiency com-
pared to a slightly hypotonic environment (0.2 M)
(Figure 3E). A greater degree of osmotic stabilization is
likely required in the growth medium compared to the
recovery medium as a result of cell-wall-weakening that
occurs in the presence of glycine. In a similar manner,
hypertonic sucrose (0.5 M) in the wash and electropor-
ation buffer greatly reduced electrotransformation
efficiency compared to an isotonic buffer (0.27 M)tion of C. pasteurianum and comparison to initial low-
High-level protocol
1.25% glycine (at OD600 0.3-0.4)
Hypertonic sucrose (0.4 M; at OD600 0.3-0.4)
OD600 0.6-0.8
Isotonic sucrose (0.27 M)
5% (v/v) ethanol 5 min prior to pulse
0.5 μg
; 6–9 ms 1.8 kV; 25 μF; ∞ Ω; 12–14 ms
Hypotonic sucrose (0.2 M)
4-6 h
pMTL85141 Up to 7.5 × 104 transformants μg-1 pMTL85141
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clostridial electrotransformation protocols that employed
phosphate-buffered sucrose as the wash and electropor-
ation buffer, as all such protocols utilize isotonic rather
than hypertonic sucrose [25,26,44-46,58,59]. Alterna-
tively, a hypertonic wash and electroporation buffer has
been shown to enhance electrotransformation of Strepto-
coccus cremoris and S. lactis [60], Listeria monocytogenes
[61], and Lactobacillus sake [62]. Based on these studies
and our data presented here it is evident that the degree
of osmotic protection required to achieve optimum
electrotransformation must be carefully determined for
each phase of the electroporation process. While it is
commonly assumed that the role of osmotic stabilizer
on cell-wall-weakened and electrotransformed cells is
strictly protective, it cannot be ruled out that higher
electrotransformation efficiencies arise, at least in part,
from faster growth rates exhibited by cultures that
actively utilize the stabilizer as a carbon and energy
source, as observed with the use of sucrose for C.
pasteurianum (this study) and Lactococcus lactis subsp.
cremoris [36].
In addition to the use of cell-wall-weakening additives,
the Gram-positive cell wall can be destabilized through
the application of high-voltage pulses during electropor-
ation, as stronger electric fields are typically required for
Gram-positive compared to Gram-negative bacteria
[23,24]. Hence, optimization of the electrical parameters
must be performed to achieve efficient electroporation
without compromising cell viability. We aimed to tailor
our electric pulse, defined by the pulse voltage (kV) and
corresponding field strength (kV cm-1), capacitance (μF),
and resistance (Ω), based on our developed glycine and
sucrose regimen. In contrast to most clostridial electropor-
ation procedures, which commonly utilize voltages of 2.0-
2.5 kV (5.0-6.25 kV cm-1), optimum electrotransformation
of glycine-treated C. pasteurianum was found to occur
under a lower voltage of 1.8 kV (4.5 kV cm-1; Figure 5A).
Within the clostridia, this low field strength has only been
matched by the described protocol for C. acetobutylicum
DSM 792 [45]. Increasing the capacitance at voltages of
either 1.8 or 2.25 kV generated significantly reduced
electrotranformation efficiencies (Figure 5B). In addition,
using a higher voltage of 2.25 kV and attempting to
truncate the duration of the pulse by using lower resis-
tances of 200 and 600 Ω also produced a reduced num-
ber of transformants (Figure 5C). Therefore, optimum
electrotransformation of glycine-treated C. pasteurianum
was found to occur under a relatively low electric field of
4.5 kV cm-1 at 25 μF and ∞ Ω, generating a time constant
of 12–14 ms. We postulate that a relatively weak elec-
tric field is best for enhancing electroporation of C.
pasteurianum as a result of the compromised cell wall
associated with the application of our glycine regimen.A similar effect has been observed using glycine-treated
cells of Bacillus cereus, in which glycine had no effect
under a high field strength (20 kV cm-1), yet a pronounced
positive effect under a low field strength (12 kV cm-1) [56].
To a lesser extent than the Gram-positive cell wall, the
cell membrane also acts as a physical barrier to transfer
of plasmid DNA into the cell. Aside from the presumed
pore formation that occurs immediately following deliv-
ery of the electric pulse, little work has been done to
enhance electroporation through increasing the extent of
membrane permeabilization. Recently, two reports have
detailed the use of ethanol as a membrane-solubilizing
agent to enhance electroporation of Escherichia coli [41]
and Oenococcus oeni [40]. The effect of ethanol, a fermen-
tation end product of C. pasteurianum, on growth of spe-
cies of Clostridium has been extensively studied and it has
been shown that ethanol toxicity occurs through direct
interaction with the cell membrane resulting in a
decreased extent of lipid organization and increased mem-
brane fluidity and cytoplasmic leakage [42,63]. It has been
proposed that leakage occurs through an ethanol-induced
increase in membrane pore size [64], which has clear im-
plications to electroporation. In this report we assessed
the electroporation-enhancing effect of ethanol and also
extended our approach to butanol. Whereas butanol
inhibited electrotransformation and cell growth of C.
pasteurianum under the conditions tested, we found that
ethanol supplemented at an appropriate concentration (5
or 10%) had a clear positive effect on electrotransformation
(Figure 4). To our knowledge, this study represents the first
use of ethanol to enhance electrotransformation within the
Clostridium genus.
The investigation of various electrotransformation
parameters enabled us to generate a maximum of 7.5 ×
104 transformants μg-1 DNA, a more than 3,000-fold in-
crease compared to our initial attempts using common
clostridial electroporation conditions (Table 3). The
results reported in this study demonstrate that C.
pasteurianum ATCC 6013 is amendable to genetic ma-
nipulation. Our hope is that our developed gene transfer
protocol will allow genetic and metabolic engineering of
C. pasteurianum and promote further development of
this biotechnologically important microorganism, as the
maximum electrotransformation efficiency attained for
C. pasteurianum is among the highest reported in the
Clostridium genus. However, significant barriers remain
to be resolved; namely the low electrotransformation
efficiency for plasmids which carry group II intron
machinery, such as pSY6catP, necessary for constructing
gene knockout mutants in clostridia. Since we have
observed a drop in electrotransformation efficiency for
pSY6catP (8,498 bp), yet not pHT3 (7,377 bp), a plasmid
of comparable size, we suspect the decrease in efficiency
is not related to plasmid size. Instead, we speculate that
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restriction-modification system, in addition to CpaAI,
that is specifically active on pSY6catP, but not on
pMTL85141. It is likely that additional uncharacterized re-
striction activities are also responsible for our inability to
electrotransform substrates methylated in vitro using CpG
and GpC methyltransferases, despite proper protection
against the previously identified CpaAI restriction endo-
nuclease. We are currently conducting genome sequen-
cing of C. pasteurianum which will enable us to identify
potential candidate restriction-modification genes that
may be responsible for the low electrotransformation effi-
ciency of certain non-pMTL85141 and in-vitro-methyl-
ated vectors. Also, it should be mentioned that, even with
the reduced electrotransformation efficiency of pSY6catP,
our electrotransformation protocol developed herein al-
lows the introduction of group II introns into the C.
pasteurianum genome in preliminary experiments (data not
shown). Thus, should genome sequencing reveal additional
restriction-modification genes, our electrotransformation
method should enable investigators to knockout such genes
using group II introns. Finally, the work here also demon-
strates that catP (using thiamphenicol) and ermB (using
clarithromycin or erythromycin) comprise effective selection
marker systems for performing genetic engineering in C.
pasteurianum. The pIM13 origin of replication from Bacil-
lus subtilis and the pCB102 and pCD6 origins of replication
from C. butyricum and C. difficile, respectively, were shown
to support plasmid maintenance in C. pasteurianum and
they round out the vector toolkit now available for genetic
engineering in this important bacterium. Taken together, the
high-level electrotransformation protocol and the vector
and selection tools described herein set the stage for bio-
technological exploitation of C. pasteurianum for the first
time, thereby opening an important avenue for the produc-
tion of biofuels from low-value and abundant crude
glycerol.
Conclusions
In this work, M.FnuDII methylation, together with cell-wall-
weakening, partial membrane solubilization, a low electric
field, and osmoprotection enabled the electrotransformation
of C. pasteurianum ATCC 6013 at an efficiency of up to
7.5 × 104 transformants ug-1 DNA. The work here also
demonstrates the development of a C. pasteurianum genetic
toolkit currently comprised of two selectable markers
(catP-based thiamphenicol selection and ermB-based
clarithromycin or erythromycin selection) and three Gram-
positive origins of replication (pIM13 from Bacillus subtilis,
pCD6 from C. difficile, and pCB102 from C. butyricum).
This is the first report of a genetic transformation proced-
ure for C. pasteurianum and represents a key advance-
ment for this industrially-important bacterium with
important implications for low-cost biofuel production.Methods
Bacterial strains, plasmids and primers
The bacterial strains, plasmids, and oligonucleotides utilized
in this work are listed in Table 2. E. coli DH5α was utilized
for routine vector construction and propagation, and E. coli
ER1821 for maintenance of M.FnuDII-methylated E. coli-C.
pasteurianum shuttle vectors. C. pasteurianum ATCC™
6013 (Winogradsky 5; W5) was acquired from the American
Type Culture Collection (Manassas, VA, USA). Modular
pMTL-series shuttle vectors [34] were kindly provided by
Prof. Nigel Minton (University of Nottingham, Nottingham,
UK). Plasmids pFnuDIIM [65], pSC12 [66], and pSY6 [47]
were respectively provided by Dr. Geoffrey Wilson (New
England Biolabs, Inc. (NEB), Ipswich, MA, USA), Prof.
George Bennett (Rice University, Houston, TX, USA),
and Prof. Sheng Yang (Shanghai Institutes for Biological
Sciences, Shanghai, China). Plasmids pHT3 [49] and
pIMP1 [26] were provided by Prof. Terry Papoutsakis
(University of Delaware, Newark, DE, USA). Oligonucleo-
tide primers were synthesized and purified by Integrated
DNA Technologies (IDT; Iowa City, IA, USA) using
standard desalting.
Bacterial growth and maintenance conditions
Unless stated otherwise, all chemicals were purchased
from Sigma-Aldrich (St. Louis, MO, USA) and stock
solutions were prepared according to the manufacturer’s
recommendations. E. coli strains were grown aerobically
at 37°C in lysogeny broth (LB; 10 g/l NaCl, 5 g/l Bacto
yeast extract, and 10 g/l Bacto tryptone). Solid and liquid
cultures of recombinant E. coli were supplemented with
100, 34, or 30 μg/ml of ampicillin, chloramphenicol, and
kanamycin, respectively. For selection of strains harbor-
ing two compatible plasmids, antibiotic concentrations
were reduced by 50%. Recombinant E. coli stocks were
stored at −80°C in 15% glycerol. Unless specified other-
wise, growth and manipulation of C. pasteurianum was
performed in a controlled anaerobic atmosphere (85% N2,
10% H2, and 5% CO2) within an anaerobic chamber (Plas-
Labs, Inc.; Lansing, MI, USA). Oxygen was purged from
growth medium by autoclaving and trace O2 was reduced
using a palladium catalyst fixed to the heating unit of the
anaerobic chamber. Agar-solidified medium was prepared
aerobically and allowed to equilibrate within the anaerobic
chamber for at least 36 hours prior to use. Anaerobic con-
ditions were monitored by addition of 1 mg/l resazurin to
both solid and liquid media. Solid and liquid cultures of
recombinant C. pasteurianum were supplemented with
15 μg/ml thiamphenicol. Cells were maintained as spores
on solidified 2×YTG (16 g/l Bacto tryptone, 10 g/l Bacto
yeast extract, 5 g/l glucose, 5 g/l NaCl, and 12 g/l agar)
plates. Sporulated agar plate stocks were prepared by
streaking colonies from an exponential-phase culture
(OD600 of 0.4-0.6) and cultivating for more than seven
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storage in air at 4°C for up to two months [67]. For long-
term storage, vegetative stock cultures (OD600 of 0.4-0.6)
were prepared and stored at −80°C in 10% glycerol by
inoculating a single sporulated plate colony into 10 ml
2×YTG and heat shocking at 80°C for 10 minutes to
induce germination.
Preparation of protoplasts and assay of CpaAI activity
Protoplasts of C. pasteurianum were prepared by sus-
pension of cells from a 100 ml culture (OD600 of 0.4-0.6)
in 25 ml of protoplast buffer (25 mM potassium phos-
phate, pH 7.0, 6 mM MgSO4, and 15% lactose)
containing 200 μg/ml lysozyme, followed by incubation
for 45 minutes anaerobically at 37°C, as described previ-
ously [19,68]. For preparation of crude protoplast lysates,
25 ml of protoplasts were collected by centrifugation at
8,500×g for 20 minutes and lysed by resuspension in
20 ml of TEMK buffer (4 mM Tris–HCl, pH 8.0, 10 mM
EDTA, 6.6 mM 2-mercaptoethanol, and 25 mM KCl)
[26]. After incubation at 37°C for 1 hour, cell debris was
cleared by centrifugation at 20,000×g for 15 minutes and
supernatants containing protoplast extracts were stored
at −80°C. CpaAI activity was assayed as previously de-
scribed [20]. Reaction mixtures contained 1.0 μg plasmid
DNA and 25% crude protoplast lysate in a total volume
of 20 μl of 1× CpaAI reaction buffer (6 mM Tris–HCl,
pH 7.4, 6 mM MgCl2, and 6 mM 2-mercaptoethanol).
Optimal digestion occurred at 37°C for 2–4 hours.
DNA Isolation and manipulation
Plasmid DNA was extracted and purified from E. coli
DH5α and ER1821 using an EZ-10 Spin Column Plas-
mid DNA Miniprep Kit from Bio Basic, Inc. (Markham,
ON, Canada). Recombinant DNA manipulations were
performed according to standard procedures [69]. Taq
DNA polymerase, restriction endonucleases, CpG (M.
SssI) and GpC (M.CviPI) methyltransferases, Quick
Ligation Kit, and 1 kb DNA ladder were purchased from
NEB (Ipswich, MA, USA). Pfu DNA polymerase and
RNase A were purchased from Bio Basic, Inc. (Markham,
ON, Canada). All commercial enzymes and kits were used
according to the manufacturer’s instructions.
Plasmid DNA was extracted and purified from C.
pasteurianum using a previously described method [49].
Briefly, 3–9 ml of late-exponential phase cells were col-
lected by centrifugation and washed twice in KET buffer
(0.5 M KCl, 0.1 M EDTA, and 0.05 M Tris–HCl, pH 8.0)
and once in SET buffer (25% sucrose, 0.05 M EDTA,
and 0.05 M Tris–HCl, pH 8.0). Cells were then
suspended in 200 μl of SET buffer containing 5 mg/ml
lysozyme and incubated anaerobically at 37°C for 20
minutes. RNase A was added to a final concentration of
100 μg/ml and cell lysis and plasmid purification werecarried out using the protocol for Purification of Low-Copy
Number Plasmid and an EZ-10 Spin Column Plasmid
DNA Miniprep Kit from Bio Basic, Inc. (Markham, ON,
Canada) beginning with addition of 400 μl of alkaline SDS
solution II.
Colony PCR of wild-type and recombinant C.
pasteurianum was performed by suspending single col-
onies in 50 μl colony lysis buffer (20 mM Tris–HCl,
pH 8.0, containing 2 mM EDTA and 1% Triton X-100),
heating in a microwave for 2 minutes at maximum
power setting, and adding 1 μl of the resulting cell
suspension to a 9 μl PCR containing Standard Taq DNA
Polymerase (NEB; Ipswich, MA, USA). An initial
denaturation of 5 minutes at 95°C was employed to fur-
ther cell lysis. Colonies screened in this manner by sus-
pension in deionized H2O failed to yield appreciable
amplification.
Vector construction
Plasmid pFnuDIIMKn was derived from pFnuDIIM to
allow methylation of E. coli-C. pasteurianum shuttle vectors
and possesses a kanamycin-resistance determinant, as both
pFnuDIIM [65] and the E. coli-C. pasteurianum shuttle
vectors used in this study carry the same chloramphenicol-
resistance marker. First, an FRT-kan-FRT PCR cassette was
amplified from plasmid pKD4 [70] using primers KnFRT.
BlpI.S and KnFRT.XhoI.AS and inserted into the MCS of
BlpI/XhoI-digested pET-20b(+) (Novagen; Madison, WI,
USA) to generate pETKnFRT. Next, the FRT-kan-FRT cas-
sette was digested out of pETKnFRT using ScaI and EcoRI
and subcloned into the corresponding restriction sites
within the catP gene of pFnuDIIM to yield pFnuDIIMKn.
Plasmid pSY6catP was derived from pSY6 [47] by
swapping the ermB marker with the catP determinant
from pSC12 [66]. The internal BsrGI recognition site
within the coding sequence of catP was mutated by
introducing two silent mutations using splicing by over-
lap extension (SOE) PCR to prevent interference with
future group II intron retargeting, which requires use of
BsrGI. The catP gene was amplified in two parts from
template pSC12 using primer sets catP.BclI.S/pSC12.
SOE.AS and pSC12.SOE.S/catP.ClaI.AS with 22 bp of
overlap between products. The resulting overlapping
PCR products were separated on a 2.0% agarose gel,
pierced three times with a P10 micropipette tip, and
used as template in a SOE PCR by cycling for 10 cycles
prior to adding primers catP.BclI.S and catP.ClaI.As and
cycling for 25 additional cycles. The mutated PCR prod-
uct was purified using a EZ-10 Spin Column PCR Prod-
ucts Purification Kit (Bio Basic, Markham, ON, Canada),
digested with BclI/ClaI, and inserted into the corre-
sponding sites of pSY6 to generate pSY6catP.
Plasmid pMTL85141ermB was derived from pMTL85141
via insertion of the ermB marker from pIMP1 into
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was PCR-amplified from template pIMP1 using primers
ermB.NdeI.S and ermB.PvuI.AS. The resulting 1,238 bp
PCR product was purified using an EZ-10 Spin Column
PCR Products Purification Kit (Bio Basic, Markham,
ON, Canada), digested with NdeI/PvuI, and inserted
into the corresponding sites of pMTL85141 to generate
pMTL85141ermB.
Preparation of electrocompetent cells and
electrotransformation
For preparation of electrocompetent cells of C.
pasteurianum using the high-level protocol, a seed cul-
ture was first prepared by inoculating 20 ml of reduced
2×YTG with 0.2 ml of a thawed glycerol stock. The cul-
ture was then 20-2-diluted and, following overnight
growth at 37°C, 1 ml of the seed culture was transferred
to a 125 ml Erlenmeyer flask containing 20 ml of re-
duced 2×YTG. Cells were grown to early exponential
phase (OD600 of 0.3-0.4), at which time filter-sterilized
stock solutions of 2 M sucrose and 18.77% glycine were
added to respective concentrations of 0.4 M and 1.25%.
Growth was resumed until the culture attained an
OD600 of 0.6-0.8 (approximately 2–3 h) and 20 ml cul-
ture was transferred to a 50 ml pre-chilled, screw-cap
centrifuge tube. At this point, all manipulations were
performed at 4°C using an ice-bath and pre-chilled re-
agents. Cells were removed from the anaerobic chamber
and collected by centrifugation at 8,500×g and 4°C for
20 minutes. The resulting cell pellet was returned to the
anaerobic chamber and washed once in 5 ml of filter-
sterilized SMP buffer (270 mM sucrose, 1 mM MgCl2,
and 5 mM sodium phosphate, pH 6.5). Following centri-
fugation, the final cell pellet was resuspended in 0.6 ml
SMP buffer.
For transfer of plasmids to C. pasteurianum, E. coli-C.
pasteurianum shuttle vectors were first co-transformed
with pFnuDIIMKn into E. coli ER1821 to methylate the ex-
ternal cytosine residue within 5’-CGCG-3’ tetranucleotide
recognition sites of CpaAI. Plasmid mixtures were then
isolated and 0.5 μg, suspended in 20 μl of 2 mM Tris–HCl,
pH 8.0, was added to 580 μl of C. pasteurianum
electrocompetent cells. The cell-DNA mixture was trans-
ferred to a pre-chilled electroporation cuvette with 0.4 cm
gap (Bio-Rad; Richmond, CA, USA), 30 μl of cold 96%
ethanol was added, and the suspension was incubated on
ice for 5 minutes. A single exponential decay pulse was ap-
plied using a Gene Pulser (Bio-Rad, Richmond, CA, USA)
set at 1.8 kV, 25 μF, and ∞ Ω, generating a time constant of
12–14 ms. Immediately following pulse delivery, the
cuvette was flooded with 1 ml 2×YTG medium containing
0.2 M sucrose and the entire suspension was transferred to
9 ml of the same medium. Recovery cultures were in-
cubated for 4–6 hours prior to plating 50–250 μlaliquots onto 2×YTG agar plates containing 15 μg/ml
thiamphenicol, 4 μg/ml clarithromycin, or 20 μg/ml
erythromycin. Plates were incubated for 2–4 days under
secondary containment within 3.4 L Anaerobic Jars each
equipped with a 3.5 L Anaerobic Gas Generating sachet
(Oxoid Thermo Fisher; Nepean, ON, Canada).
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